UNSPSC 51283937: Mafenide acetate

This classification denotes a topical anti-infective agent with the molecular formula C7H10N2O2S.C2H4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RQ6LP6Z0WY, chemically known as p-toluenesulfonamide, alpha-amino-, monoacetate but more generally known as mafenide acetate, which bears US NIH Compound Identifier 25590. European Medicines Agency schedules Mafenide acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02998MIG.

Most nations, for tariff and trade purposes, schedule mafenide acetate under HS 29350090 and SITC 51580. As of Q4 2014, MAFENIDE ACETATE remains US FDA's Preferred Term for this commodity. Mafenide acetate bears US NLM identifiers UMLS ID C0809894 and NCI Concept Code C47591. SMILES: CC(=O)O.C1CC(CCC1CN)S(=O)(=O)N.

UNSPSC 51283937 Mafenide acetate is a Commodity code for a specific pharmaceutical active ingredient used in topical burn-wound treatment. State and local solicitations under this code show little recent activity aligned with the code's nominal scope; the two most recent opportunities in the dataset are pharmaceutical procurements by Illinois Department of Public Health and Seminole County, Florida, but neither is acquiring mafenide acetate. The Illinois Department of Public Health awarded a piggyback contract through the MMCAP cooperative purchasing vehicle for Doxycycline Hyclate and Ciprofloxacin Hydrochloride—antibiotics unrelated to the mafenide code—to Chartwell Rx LLC. Seminole County released an ITB for Naloxone and Safe Drug Deactivation Systems, also outside the code's scope. Both procurements reflect state and local demand for pharmaceutical products through volume cooperative agreements and standardized bidding, but the code itself does not appear in active state and local RFPs, RFQs, or ITBs at present.

Activity is concentrated in Florida and Illinois based on the recent opportunities, though the mismatch between the code designation and the actual goods being purchased suggests this code sees minimal or mistagged procurement volume at the state and local level. The Illinois MMCAP contract awarded to Chartwell Rx LLC valued $2,999,999.11 over 12 months with renewal options for years two and three. The Seminole County ITB, posted June 30, 2026 with a response date of July 26, 2023, targeted 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries. Neither opportunity involves mafenide acetate acquisition or a purchasing body seeking this code specifically.